rs34861192
This variant is located in the RETN gene.
▶GWAS Catalog Trait Associations (1)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
GWAS Catalog Trait Associations (1)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
resistin measurement
▶Research that mentions this SNP (4)
▶Epigenome-wide association study suggests that SNPs in the promoter region of RETN influence plasma resistin level via effects on DNA methylation at neighbouring sitesAssociationN=479Masahiro Nakatochi et al.(2015)· Diabetologia
This epigenome-wide association study (EWAS) in 192 elderly Japanese men identified DNA methylation site cg02346997 in the RETN promoter region as significantly associated with plasma resistin level (p=6.02×10⁻¹⁰). The study found that RETN SNPs rs34861192 and rs3219175 were negatively associated with methylation at cg02346997 (p=4.43×10⁻¹⁷), suggesting these promoter SNPs influence circulating resistin through effects on DNA methylation and RETN mRNA abundance.
▶Association of TCF7L2 SNPs with age at onset of type 2 diabetes and proinsulin/insulin ratio but not with glucagon‐like peptide 1AssociationN=26Guenther Silbernagel et al.(2011)· Diabetes/Metabolism Research and Reviews
This association study analyzed four T2D-related SNPs (rs5219, rs1801282, rs7903146, rs12255372) in 26 Yakut patients with type 2 diabetes via pyrosequencing. No statistically significant differences were found between Yakut T2D cases and control groups for KCNJ11, PPARG, or TCF7L2 polymorphisms. The study identified strong linkage disequilibrium between TCF7L2 rs7903146 and rs12255372 (D'=1, LOD=4.92) in Yakuts and demonstrated that the risk T-allele frequency of TCF7L2 SNPs is notably lower in Asian populations (3.8% in Yakuts, 2-3% in Japanese and Chinese) compared to European and African populations.
▶Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese populationAssociationN=3,133Asano H. et al.(2010)· Diabetologia
In an aged Japanese cohort of 3,133 participants from the KING study, plasma resistin concentration was significantly associated with two RETN polymorphisms: rs34861192 (the most prominent, explaining 35.9% of variance) and rs3745368. These variants independently determined resistin levels and resistin levels were associated with metabolic traits including dyslipidemia, insulin concentration, and obesity.
▶Is rs34861192 or rs1862513 a more promising variant for determining plasma resistin in an aged Japanese population?ReviewOsawa H. et al.(2010)· Diabetologia
This is a letter to the editor commenting on a study of resistin gene SNPs in an aged Japanese population. The authors argue that rs1862513 (SNP-420C>G) should still be considered a promising causal variant for determining plasma resistin levels, despite statistical analyses suggesting rs34861192 (SNP-638G>A) as the stronger determinant. The authors note that functional data supports rs1862513's role through transcription factor binding, and that population-specific allele frequencies and linkage disequilibrium limitations make it difficult to distinguish the causal variant from association statistics alone.
About RETN
This gene belongs to the family defined by the mouse resistin-like genes. The characteristic feature of this family is the C-terminal stretch of 10 cys residues with identical spacing. The mouse homolog of this protein is secreted by adipocytes, and may be the hormone potentially linking obesity to type II diabetes. The encoded protein also has an antimicrobial role in skin, displaying antibacterial activity against both Gram positive and Gram negative bacteria. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2020]
View all RETN variants →Gene information from NCBI Gene. Variant classifications from ClinVar.
Community Wiki
No community notes yet for this variant. Sign in to start one.
Comments
Sign in to join the discussion.
Loading comments…